Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir + Ribavirin in HCV/HIV Coinfection (PHOTON-1)
NCT01667731Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Jul 2012; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01667731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667731.